Dr. Pramod Kashid

Expecto Health Science is a rapidly growing clinical research organization (CRO) dedicated to delivering high-quality, end-to-end clinical trial solutions across the pharmaceutical, biotechnology, and medical device sectors. With a strong presence in the Asia-Pacific region, the organization specializes in managing Phase II–IV clinical trials, post-marketing surveillance (PMS), observational and interventional studies, and retrospective research. Backed by a team of experienced professionals, Expecto Health Science combines scientific expertise with operational excellence to ensure efficient study execution, regulatory compliance, and data integrity. The company is committed to supporting sponsors with tailored, cost-effective strategies that accelerate timelines while maintaining the highest standards of quality and ethics. Through strategic collaborations and partnerships, Expecto continues to expand its global footprint, offering localized expertise with a global perspective. Its patient-centric approach, advanced technology integration, and strong investigator network enable seamless study delivery across diverse therapeutic areas. Driven by innovation and a commitment to excellence, Expecto Health Science aims to be a trusted partner in advancing clinical research and improving patient outcomes worldwide.